The 'Worst-Case Scenario' — Why Insmed Just Reversed Its 181% Six-Month Sprint
Summarize this article with:
BREAKING: Futures Mixed, Micron Jumps After AI-Led Sell-OffInsmed (INSM) stock crumbled late Wednesday after the biotech company scrapped one of its brensocatib studies in what one analyst called a "worst-case scenario for the program." The company said brensocatib missed the goals of a Phase 2 study in patients with chronic rhinosinusitis without nasal polyps, or CRSsNP.
Insmed Chief Medical Officer Martina Flammer noted that there are no… 11/28/2025 Biotech stocks have a strong presence on the elite IBD 50 list of growth stocks. 11/28/2025 Biotech stocks have a strong presence on the elite IBD... Get instant access to exclusive stock lists, expert market analysis and powerful tools with 2 months of IBD Digital for only $20!Get market updates, educational videos, webinars, and stock analysis.Learn how you can make more money with IBD's investing tools, top-performing stock lists, and educational content.Information in Investor’s Business Daily is for informational and educational purposes only and should not be construed as an offer, recommendation, solicitation, or rating to buy or sell securities. The information has been obtained from sources we believe to be reliable, but we make no guarantee as to its accuracy, timeliness, or suitability, including with respect to information that appears in closed captioning. Historical investment performances are no indication or guarantee of future success or performance. Authors/presenters may own the stocks they discuss. We make no representations or warranties regarding the advisability of investing in any particular securities or utilizing any specific investment strategies. Information is subject to change without notice. For information on use of our services, please see our Terms of Use.*Real-time prices by Nasdaq Last Sale. Real-time quote and/or trade prices are not sourced from all markets. Ownership data provided by LSEG and Estimate data provided by FactSet.IBD, IBD Digital, IBD Live, IBD Weekly, Investor's Business Daily, Leaderboard, MarketDiem, MarketSurge and other marks are trademarks owned by Investor's Business Daily, LLC.©2025 Investor’s Business Daily, LLC.
All Rights Reserved.